We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.73B
AUM Growth
+$152M
Cap. Flow
-$38.6M
Cap. Flow %
-2.23%
Top 10 Hldgs %
25.39%
Holding
270
New
10
Increased
28
Reduced
188
Closed
10

Top Buys

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$11.2M
2
PBH icon
Prestige Consumer Healthcare
PBH
+$6.68M
3
VRNA
Verona Pharma
VRNA
+$6.54M
4
ADUS icon
Addus HomeCare
ADUS
+$3.51M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$2.65M

Top Sells

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$11.2M
2
LRN icon
Stride
LRN
+$9.83M
3
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
+$9.14M
4
AX icon
Axos Financial
AX
+$5.93M
5
DEN
Denbury Inc.
DEN
+$3.51M

Sector Composition

Rank Sector Weight
1 Healthcare 30.1%
2 Technology 23.78%
3 Industrials 19.23%
4 Consumer Discretionary 6.36%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBYI icon
201
Puma Biotechnology
PBYI
$454M
$1.43M 0.08%
329,870
-33,796
-9% -$112K
JNJ icon
202
Johnson & Johnson
JNJ
$625B
$1.43M 0.08%
9,111
– –
CODA icon
203
Coda Octopus Group
CODA
$120M
$1.42M 0.08%
235,225
-15,803
-6% -$98.5K
ZYXI
204
DELISTED
Zynex
ZYXI
$1.31M 0.08%
120,429
+91,822
+321% +$817K
OPTN
205
DELISTED
OptiNose
OPTN
$1.3M 0.08%
66,992
-3,013
-4% -$55K
BRKR icon
206
Bruker
BRKR
$8.14B
$1.29M 0.07%
17,524
– –
MIRM icon
207
Mirum Pharmaceuticals
MIRM
$6.14B
$1.26M 0.07%
42,840
-10,539
-20% -$319K
XOM icon
208
ExxonMobil
XOM
$634B
$1.21M 0.07%
12,057
+8,407
+230% +$884K
CR icon
209
Crane Co
CR
$12.7B
$1.15M 0.07%
9,713
– –
ZBH icon
210
Zimmer Biomet
ZBH
$18.4B
$1.11M 0.06%
9,159
– –
TECH icon
211
Bio-Techne
TECH
$11.3B
$1.11M 0.06%
14,432
– –
CMBM
212
DELISTED
Cambium Networks
CMBM
$1.11M 0.06%
184,214
-632,577
-77% -$3.11M
LLY icon
213
Eli Lilly
LLY
$1.06T
$1.1M 0.06%
1,890
– –
URGN icon
214
UroGen Pharma
URGN
$2.29B
$1.05M 0.06%
69,892
-5,288
-7% -$68.6K
KNX icon
215
Knight Transportation
KNX
$11.4B
$1.03M 0.06%
17,877
– –
EVC icon
216
Entravision Communication
EVC
$1.1B
$1.01M 0.06%
243,230
-11,003
-4% -$43.5K
BRK.B icon
217
Berkshire Hathaway Class B
BRK.B
$1.13T
$999K 0.06%
2,800
– –
DOV icon
218
Dover
DOV
$28.4B
$955K 0.06%
6,210
-10
-0.2% -$1.4K
THS
219
DELISTED
Treehouse Foods
THS
$905K 0.05%
21,830
-33
-0.2% -$1.35K
EXEL icon
220
Exelixis
EXEL
$13.4B
$903K 0.05%
37,645
-74
-0.2% -$1.61K
EW icon
221
Edwards Lifesciences
EW
$51.7B
$888K 0.05%
11,649
– –
TBRG
222
DELISTED
TruBridge
TBRG
$849K 0.05%
75,829
-122,050
-62% -$1.55M
SRRK icon
223
Scholar Rock
SRRK
$6.44B
$829K 0.05%
44,080
-3,293
-7% -$40.9K
KEX icon
224
Kirby Corp
KEX
$6.93B
$806K 0.05%
10,268
– –
DENN
225
DELISTED
Denny's
DENN
$796K 0.05%
73,137
-4,868
-6% -$45.8K
7 8
9
10 11

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Rice Hall James & Associates held 270 positions worth $1.73B, up 9.7% from $1.57B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates's Q4 2023 filing shows 10 new, 28 increased, 188 reduced and 10 closed positions. Its largest new stake was Addus HomeCare: 40,418 shares worth $3.75M. The largest sale was Bed Bath & Beyond, an estimated $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q4 2023 buy was Addus HomeCare: 40,418 shares worth $3.75M.
  • Rice Hall James & Associates added most to Establishment Labs in Q4 2023, an estimated $11.2M increase.
  • Rice Hall James & Associates's biggest Q4 2023 reduction was Bed Bath & Beyond, cutting an estimated $11.2M.
  • Rice Hall James & Associates fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $9.14M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.73B portfolio in Q4 2023.
  • Rice Hall James & Associates opened 10 new positions and closed 10 in Q4 2023.
  • Rice Hall James & Associates's portfolio value rose 9.7% quarter-over-quarter to $1.73B.

Based on Rice Hall James & Associates's 13F filing for Q4 2023, filed 9 Feb 2024.